R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples